XML 45 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Intangible Assets (Tables)
 6 Months Ended
Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Reconciliation of Intangible Assets
The reconciliation of intangible assets for the six months ended December 31, 2018 and for the years ended June 30, 2018 and 2017 was as follows (in thousands):
 
 
 
Six Months Ended
 
 
Year Ended
 
 
 
December 31,
 
 
June 30,
 
 
 
2018
 
 
2018
 
 
2017
 
Patented technologies
 
 
 
 
 
 
 
 
 
 
 
 
Gross carrying amount at beginning of period
 
$
68,322
 
 
$
35,610
 
 
$
36,196
 
Acquisition of Icon Bioscience Inc.
 
 
—
 
 
 
31,973
 
 
 
—
 
Foreign currency translation adjustments
 
 
—
 
 
 
739
 
 
 
(586
)
Gross carrying amount at end of period
 
 
68,322
 
 
 
68,322
 
 
 
35,610
 
Accumulated amortization at beginning of period
 
 
(36,964
)
 
 
(35,246
)
 
 
(35,094
)
Amortization expense
 
 
(1,229
)
 
 
(981
)
 
 
(724
)
Foreign currency translation adjustments
 
 
—
 
 
 
(737
)
 
 
572
 
Accumulated amortization at end of period
 
 
(38,193
)
 
 
(36,964
)
 
 
(35,246
)
Net book value at end of period
 
$
30,129
 
 
$
31,358
 
 
$
364
 
Schedule of Net Book Value of Intangible Assets
The net book value of the Company’s intangible assets at December 31, 2018, June 30, 2018
and June 30, 2017 is summarized as follows (in thousands):
 
 
 
 
 
 
 
 
 
 
 
 
Estimated
 
 
 
 
 
 
 
 
 
 
 
 
Remaining
 
 
 
 
 
 
 
 
 
 
 
 
Useful Life at
 
 
 
December 31,
 
 
June 30,
 
 
December 31,
 
 
 
2018
 
 
2018
 
 
2017
 
 
2018
 
 
 
 
 
 
 
 
 
 
 
 
(Years)
 
Patented technologies
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DEXYCU / Verisome
 
$
30,129
 
 
$
31,358
 
 
$
—
 
 
 
12.25
 
Durasert
 
 
—
 
 
 
—
 
 
 
265
 
 
 
—
 
Tethadur
 
 
—
 
 
 
—
 
 
 
99
 
 
 
—
 
 
 
$
30,129
 
 
$
31,358
 
 
$
364